Synergistic antitumor activity of aspirin and erlotinib: Inhibition of p38 enhanced aspirin plus erlotinib‑induced suppression of metastasis and promoted cancer cell apoptosis
Xiu Hu(Zhejiang University), Chong Zhang(Zhejiang University)
Cited by 17
Related Papers
In vitro anti-cancer activity of chamaejasmenin B and neochamaejasmin C isolated from the root of Stellera chamaejasme L
|Acta Pharmacologica Sinica|2012|49
<p>Harmine suppresses the proliferation of pancreatic cancer cells and sensitizes pancreatic cancer to gemcitabine treatment</p>
|OncoTargets and Therapy|2019|42
DYRK1A suppression attenuates HIF‑1α accumulation and enhances the anti‑liver cancer effects of regorafenib and sorafenib under hypoxic conditions
|International Journal of Oncology|2022|16
Enhanced antitumor activity by the combination of dasatinib and combretastatin A-4 in vitro and in vivo
|Oncology Reports|2013|8
TSPAN6 reinforces the malignant progression of glioblastoma via interacting with CDK5RAP3 and regulating STAT3 signaling pathway
|International Journal of Biological Sciences|2024|7